{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:39:09Z","timestamp":1782815949251,"version":"3.54.5"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) is a global public health concern characterized by progressive renal function decline and fibrosis, ultimately leading to end-stage renal disease (ESRD). Renal tubular injury and renal interstitial fibrosis are key contributor to this process. Granzyme B (GZMB), a serine protease, has been studied for its role in inducing apoptosis during immune defense. However, the role of GZMB in tubular injury and renal interstitial fibrosis remain unclear. Nafamostat mesylate (NM), a broad-spectrum serine protease inhibitor which is used for anticoagulation during hemodialysis in the clinic. This study aims to investigate the effects of GZMB on renal injury and renal interstitial fibrosis, and further explore the mechanisms of action NM intervention on renal injury and renal interstitial fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      To elucidate the therapeutic mechanisms of NM in renal fibrosis, we integrated\n                      <jats:italic>in vivo<\/jats:italic>\n                      unilateral ischemia-reperfusion injury (UIRI) models with\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments using human proximal tubular epithelial (HK-2) cells stimulated by TGF-\u03b2 or GZMB. The therapeutic effect of NM was evaluated through renal function examination, histopathological assessment, immunofluorescence staining, Western blot and qRT-PCR analysis. In addition, RNA sequencning is conducted to identify key pathways. These methods collectively reveal the mechanisms both\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      by NM improves renal injury and fibrosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      GZMB was upregulated in various mouse models of renal fibrosis as well as in TGF-\u03b2-stimulated HK-2 cells.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , GZMB treatment induced HK-2 cell injury, inflammatory responses, and partial epithelial-mesenchymal transition (p-EMT). Transcriptomic analysis demonstrated that the combined administration of GZMB and perforin significantly altered the expression of genes associated with apoptosis, inflammation, and fibrosis. The serine protease inhibitor NM attenuated GZMB-induced HK-2 cell injury, inflammatory responses, and p-EMT. Furthermore, NM suppressed TGF-\u03b2-induced p-EMT. In a murine model of UIRI, NM administration improved renal function, reduced fibrotic deposition, and exerted protective effects against apoptosis and mitochondrial dysfunction. RNA-seq analysis suggested that the renoprotective effects of NM were mediated through inhibition of the IL-17\/c-Fos signaling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study confirmed that GZMB promotes the process of renal fibrosis by inducing renal tubular cell injury and p-EMT. NM can effectively antagonize the above-mentioned harmful effects induced by GZMB and TGF-\u03b2, and improve renal function and alleviate fibrosis in mouse models. Its renal protective effect is related to the inhibition of the IL-17\/c-Fos signaling pathway. The above content proves that NM can be a potential drug for the treatment of CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1648623","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:25:09Z","timestamp":1761888309000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway"],"prefix":"10.3389","volume":"16","author":[{"given":"Weili","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuman","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.0105-2896.2010.00907.x","article-title":"Functional dissection of the granzyme family: cell death and inflammation","volume":"235","author":"Anthony","year":"2010","journal-title":"Immunol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"21261","DOI":"10.1074\/jbc.273.33.21261","article-title":"Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B","volume":"273","author":"Atkinson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1038\/s41467-024-47574-0","article-title":"Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation","volume":"15","author":"Berjis","year":"2024","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.7150\/ijbs.26111","article-title":"Neutrophil elastase inhibitors and chronic kidney disease","volume":"14","author":"Bronze-da-Rocha","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"eaar8356","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4(+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.3390\/ijms21093172","article-title":"The role of chemokines and chemokine receptors in diabetic nephropathy","volume":"21","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00011-023-01794-0","article-title":"Nafamostat mesilate prevented caerulein-induced pancreatic injury by targeting HDAC6-mediated NLRP3 inflammasome activation","volume":"72","author":"Chen","year":"2023","journal-title":"Inflamm. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1371743","DOI":"10.3389\/fimmu.2024.1371743","article-title":"Granzymes in health and diseases: the good, the bad and the ugly","volume":"15","author":"Cigalotto","year":"2024","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"589188","DOI":"10.3389\/fimmu.2020.589188","article-title":"Granzyme B expression in visceral adipose tissue associates with local inflammation and glyco-metabolic alterations in obesity","volume":"11","author":"Cimini","year":"2020","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.kisu.2017.07.002","article-title":"Action plan for determining and monitoring the prevalence of chronic kidney disease","volume":"7","author":"Coresh","year":"2017","journal-title":"Kidney Int. Suppl."},{"key":"B12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/cns.12801","article-title":"Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury","volume":"24","author":"Duan","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.it.2009.01.002","article-title":"Granule-associated serine proteases: granzymes might not just be killer proteases","volume":"30","author":"Froelich","year":"2009","journal-title":"Trends Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1400553","DOI":"10.3389\/fimmu.2024.1400553","article-title":"Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH","volume":"15","author":"Gr\u00f8ndal","year":"2024","journal-title":"Front. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"F852-F863","DOI":"10.1152\/ajprenal.00564.2015","article-title":"An additive effect of anti-PAI-1 antibody to ACE inhibitor on slowing the progression of diabetic kidney disease","volume":"311","author":"Gu","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"931670","DOI":"10.3389\/fphar.2022.931670","article-title":"Integration of transcriptomics and metabolomics reveals the molecular mechanisms underlying the effect of nafamostat mesylate on rhabdomyolysis-induced acute kidney injury","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jointm.2024.02.003","article-title":"Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: potential targets for nafamostat mesilate","volume":"4","author":"He","year":"2024","journal-title":"J. Intensive Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.15252\/embr.201744351","article-title":"Regulation of perforin activation and pre-synaptic toxicity through C-terminal glycosylation","volume":"18","author":"House","year":"2017","journal-title":"EMBO Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/cdd.2014.180","article-title":"Granzyme B-induced mitochondrial ROS are required for apoptosis","volume":"22","author":"Jacquemin","year":"2015","journal-title":"Cell Death Differ."},{"key":"B21","doi-asserted-by":"publisher","first-page":"119155","DOI":"10.1016\/j.lfs.2021.119155","article-title":"Toll-like receptor 4: an attractive therapeutic target for acute kidney injury","volume":"271","author":"Jha","year":"2021","journal-title":"Life Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"pwaf020","DOI":"10.1093\/procel\/pwaf020","article-title":"Neutrophil extracellular traps license macrophage production of chemokines to facilitate CD8+ T cell infiltration in obstruction-induced renal fibrosis","author":"Jia","year":"2025","journal-title":"Protein Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.7150\/thno.63735","article-title":"Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathy","volume":"12","author":"Jiang","year":"2022","journal-title":"Theranostics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/hep.0000000000000830","article-title":"Antagonistic effects of the cytotoxic molecules granzyme B and TRAIL in the immunopathogenesis of sclerosing cholangitis","volume":"80","author":"Kellerer","year":"2024","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/resp.12069","article-title":"A possible role for CD8+ and non-CD8+ cell granzyme B in early small airway wall remodelling in centrilobular emphysema","volume":"18","author":"Kim","year":"2013","journal-title":"Respirology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/ijms23020843","article-title":"The dynamics and plasticity of epigenetics in diabetic kidney disease: therapeutic applications Vis-\u00e0-Vis","volume":"23","author":"Kuo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"102868","DOI":"10.1016\/j.redox.2023.102868","article-title":"Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis","volume":"67","author":"Li","year":"2023","journal-title":"Redox Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.cell.2023.12.015","article-title":"Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"879326","DOI":"10.1155\/2014\/879326","article-title":"The effect of serine protease inhibitors on airway inflammation in a chronic allergen-induced asthma mouse model","volume":"2014","author":"Lin","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"B30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","article-title":"Renal tubule injury: a driving force toward chronic kidney disease","volume":"93","author":"Liu","year":"2018","journal-title":"Kidney Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"F173","DOI":"10.1152\/ajprenal.00586.2012","article-title":"The antifibrotic effect of a serine protease inhibitor in the kidney","volume":"305","author":"Morinaga","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1681\/asn.0000000000000116","article-title":"Transcriptional and clonal characterization of cytotoxic T cells in crescentic glomerulonephritis","volume":"34","author":"Mueller","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/1753465809341965","article-title":"The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary disease","volume":"3","author":"Ngan","year":"2009","journal-title":"Ther. Adv. Respir. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"101152","DOI":"10.1016\/j.mam.2022.101152","article-title":"Beyond target cell death - granzyme serine proteases in health and disease","volume":"88","author":"N\u00fcssing","year":"2022","journal-title":"Mol. Asp. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10456-024-09909-9","article-title":"Granzyme B degrades extracellular matrix and promotes inflammation and choroidal neovascularization","volume":"27","author":"Obasanmi","year":"2024","journal-title":"Angiogenesis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"F176","DOI":"10.1152\/ajprenal.00107.2016","article-title":"C-reactive protein exacerbates renal ischemia-reperfusion injury: are myeloid-derived suppressor cells to blame?","volume":"311","author":"Pegues","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.4430","article-title":"IL-17A produced by both \u03b3\u03b4 T and Th17 cells promotes renal fibrosis via RANTES-Mediated leukocyte infiltration after renal obstruction","volume":"235","author":"Peng","year":"2015","journal-title":"J. Pathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1084\/jem.20181454","article-title":"NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing","volume":"216","author":"Prager","year":"2019","journal-title":"J. Exp. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"120527","DOI":"10.1016\/j.lfs.2022.120527","article-title":"Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-\u03b21\/Smad2\/3 and NF-kB\/NLRP3 signaling axis in mice","volume":"298","author":"Ram","year":"","journal-title":"Life Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"10587","DOI":"10.1039\/d2fo01384c","article-title":"Carvacrol preserves antioxidant status and attenuates kidney fibrosis via modulation of TGF-\u03b21\/Smad signaling and inflammation","volume":"13","author":"Ram","year":"","journal-title":"Food Funct."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41467-021-21737-9","article-title":"Cytotoxic CD8(+) T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling","volume":"12","author":"Santos-Zas","year":"2021","journal-title":"Nat. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1053\/j.gastro.2017.10.018","article-title":"Cathepsin B-Mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice","volume":"154","author":"Sendler","year":"2018","journal-title":"Gastroenterology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ajpath.2015.09.010","article-title":"Granzyme B deficiency protects against angiotensin II-Induced cardiac fibrosis","volume":"186","author":"Shen","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1392535","DOI":"10.3389\/fimmu.2024.1392535","article-title":"Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentials","volume":"15","author":"Thompson","year":"2024","journal-title":"Front. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.matbio.2017.12.005","article-title":"Granzyme B in skin inflammation and disease","author":"Turner","year":"2019","journal-title":"Matrix Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jid.2020.05.095","article-title":"Granzyme B contributes to barrier dysfunction in oxazolone-induced skin inflammation through E-Cadherin and FLG cleavage","volume":"141","author":"Turner","year":"2021","journal-title":"J. Invest Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"587581","DOI":"10.3389\/fimmu.2020.587581","article-title":"Granzyme B in inflammatory diseases: apoptosis, inflammation, extracellular matrix remodeling, epithelial-to-mesenchymal transition and fibrosis","volume":"11","author":"Velotti","year":"2020","journal-title":"Front. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"105325","DOI":"10.1016\/j.antiviral.2022.105325","article-title":"Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins","volume":"202","author":"Yan","year":"2022","journal-title":"Antivir. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1093\/ndt\/gfz050","article-title":"Fibroblast-specific plasminogen activator inhibitor-1 depletion ameliorates renal interstitial fibrosis after unilateral ureteral obstruction","volume":"34","author":"Yao","year":"2019","journal-title":"Nephrol. Dial. Transpl."},{"key":"B51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12974-021-02357-y","article-title":"Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness","volume":"19","author":"Yates","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1042\/cs20201161","article-title":"Protective role of kallistatin in renal fibrosis via modulation of Wnt\/\u03b2-catenin signaling","volume":"135","author":"Yiu","year":"2021","journal-title":"Clin. Sci. (Lond)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41467-022-28096-z","article-title":"A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-\u03b2 signaling","volume":"13","author":"Yuan","year":"","journal-title":"Nat. Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"","journal-title":"Signal Transduct. Target Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"109804","DOI":"10.1016\/j.cellsig.2020.109804","article-title":"Granzymes in cardiovascular injury and disease","volume":"76","author":"Zeglinski","year":"2020","journal-title":"Cell Signal"},{"key":"B56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yjmcc.2018.01.001","article-title":"Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice","volume":"115","author":"Zhang","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.3390\/ijms25126585","article-title":"Kidney aging and chronic kidney disease","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12974-022-02531-w","article-title":"Delayed administration of nafamostat mesylate inhibits thrombin-mediated blood-spinal cord barrier breakdown during acute spinal cord injury in rats","volume":"19","author":"Zhao","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4049\/jimmunol.169.3.1319","article-title":"A role for NF-kappa B activation in perforin expression of NK cells upon IL-2 receptor signaling","volume":"169","author":"Zhou","year":"2002","journal-title":"J. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"eaaz7548","DOI":"10.1126\/science.aaz7548","article-title":"Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells","volume":"368","author":"Zhou","year":"2020","journal-title":"Science"}],"updated-by":[{"DOI":"10.3389\/fphar.2025.1764700","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1648623\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T09:37:15Z","timestamp":1766482635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1648623\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":59,"alternative-id":["10.3389\/fphar.2025.1648623"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1648623","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"1648623"}}